Unique ID issued by UMIN | UMIN000030018 |
---|---|
Receipt number | R000033852 |
Scientific Title | CT fluoroscopy-guided biopsy using a robot (Zerobot) for needle insertion:single-center, single-arm, open-label, prospective, first-in-human, feasibility trial |
Date of disclosure of the study information | 2017/11/17 |
Last modified on | 2018/10/12 12:04:26 |
CT fluoroscopy-guided biopsy using a robot (Zerobot) for needle insertion:single-center, single-arm, open-label, prospective, first-in-human, feasibility trial
CT fluoroscopy-guided biopsy using a robot (Zerobot) for needle insertion
CT fluoroscopy-guided biopsy using a robot (Zerobot) for needle insertion:single-center, single-arm, open-label, prospective, first-in-human, feasibility trial
CT fluoroscopy-guided biopsy using a robot (Zerobot) for needle insertion
Japan |
cancer
Medicine in general | Gastroenterology | Hepato-biliary-pancreatic medicine |
Pneumology | Hematology and clinical oncology | Surgery in general |
Hepato-biliary-pancreatic surgery | Chest surgery | Radiology |
Malignancy
NO
Feasibility of CT fluoroscopy-guided biopsy with Zerobot
Safety
Exploratory
Phase I
Feasibility of CT fluoroscopy-guided biopsy with Zerobot, which is evaluated by inserting a biopsy introducer needle into the lesion or near the lesion on CT images
Safety of CT fluoroscopy-guided biopsy with Zerobot, which is evaluated by adverse events and machine trouble of throbot
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Device,equipment |
1 day, 1 time
20 | years-old | <= |
Not applicable |
Male and Female
1) patients who have a target lesion for which pathological diagnosis is required
2) patients with platelet count > 30,000/mm3
3) patients with PT-INR < 1.5
4) patients of 20-years-old or older
5) patients for whom informed consent is obtained
6) patients with a target lesion of at least 10-mm in diameter
7) patients with needle insertion length < 11 cm
1) patients who cannot limit body motion or hold their breath
2) patients whose needle tract for a target lesion is near (<10 mm) organs at risk such as the heart and aorta, gastrointestinal tract, pancreas, etc
3) patients who cannot stop antiplatelet or anticoagulant agents
4) patients who cannot undergo anesthesia
5) patients whose target lesion is in the head and neck, central nerve system, spinal cord, heart or aorta, and gastrointestinal tract
6) patients in whom the bone is an obstacle in needle tract
7) patients who undergo biopsy with other methods during study period
8) patients who undergo invasive therapy including chemotherapy, radiation, and surgery during study period
9) patients with mental disorder under treatment
10) pregnant patients
11) patients whom a physician judgesto be inappropriate
1
10
1st name | |
Middle name | |
Last name | Tako Hiraki |
Okayama University Graduate Shool of Medicine, Dentistry and Pharmaceutical Sciences
Department of Radiology
Kitaku, Shikatacho 2-5-1, Okayama
086-235-7313
takaoh@tc4.so-net.ne.jp
1st name | |
Middle name | |
Last name | Tako Hiraki |
Okayama University Graduate Shool of Medicine, Dentistry and Pharmaceutical Sciences
Department of Radiology
Kitaku, Shikatacho 2-5-1, Okayama
086-235-7313
takaoh@tc4.so-net.ne.jp
Okayama University Graduate Shool of Medicine, Dentistry and Pharmaceutical Sciences
Okayama University Graduate Shool of Medicine, Dentistry and Pharmaceutical Sciences
Other
NO
2017 | Year | 11 | Month | 17 | Day |
Unpublished
Open public recruiting
2017 | Year | 10 | Month | 18 | Day |
2018 | Year | 04 | Month | 01 | Day |
2017 | Year | 11 | Month | 17 | Day |
2018 | Year | 10 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033852